Are you interested in how AI is transforming drug design? Join Dr. Wang as he explores how advances in AI-driven protein folding are accelerating rational drug design and overcoming long-standing limitations in structural biology.

He will also address the challenge of modeling the “GluePlex” - the ternary complex formed by and E3 ligase, a molecular glue and neo-substrate. These advances now allow researchers to predict protein interactions, design molecular glues more efficiently and identify new degraders without relying on traditional structures.